The effect of somatostatin analog octreotide (Sandostatin®) on luteinizing hormone and ovarian steroids in insulin-dependent diabetic women without residual insulin secretion.
Autor: | Prelevićć, G. M., Wurzburger, M. I., Balint-Perićć, L. |
---|---|
Zdroj: | Gynecological Endocrinology; 1992, Vol. 6 Issue 4, p259-263, 5p |
Databáze: | Complementary Index |
Externí odkaz: |